Academician profile · DOÇENT
ANT UZAY
ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Hematoloji (İç Hastalıkları)
- TIP FAKÜLTESİ
- DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
10
Q2
5
Q3
10
Q4
4
WoS (JCR)
Q1
5
Q2
6
Q3
6
Q4
12
TR Index
8
articles
Articles
- 2025 The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation
- 2025 The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes
- 2025 BEGEV is an Effective Therapy for Heavily Pretreated and Platinum-Resistant Relapsed/Refractory Hodgkin’s Lymphoma Patients: A Single Center Real-Life Experience
- 2025 Is there a relationship between stem cell yield obtained from healthy donors and healthy donors’ blood type?
- 2025 Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study
- 2025 The comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma
- 2025 Does body mass index affect stem cell yield in healthy donors?
- 2025 A Case of Kappa Light-Chain Multiple Myeloma With Auer Rod-Like Inclusions and Snapper-Schneid Granules
- 2025 C-reactive Protein Guided Empirical Antibiotic Therapy Versus Standardized Neutropenic Fever Approach in Patients Undergoing High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation
- 2025 Elranatamab in Heavily Pretreated Triple-class Refractory Multiple Myeloma: A Single-center Experience
- 2025 Farklı Molekül Ağırlığındaki Hidroksietil Nişasta ve %0,9 İzotonik NaCl Solüsyonlarının Trombosit Agregasyon Fonksiyonları Üzerine İn Vitro Etkisi
- 2024 Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center
- 2024 Comparison of single day versus two-and three- day fractionated infusion of peripheral stem cells in autologous transplantation
- 2023 Daily low dose intravesical cidofovir for the treatment of BK virus associated hemorrhagic cystitis after allogeneic stem cell transplantation
- 2023 Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data
- 2023 Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey
- 2023 Atypical presentation of medication-related osteonecrosis of the jaw in a young male patient undergoing chemotherapy for acute lymphoblastic leukemia
- 2022 Effects of neuromuscular electrical stimulation combined with resistance exercises on muscle strength in adult hematological cancer patients: A randomized controlled study
- 2021 Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study
- 2021 Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease